|
1
|
Au JS and Frenette CT: Management of
hepatocellular carcinoma: Current status and future directions. Gut
Liver. 9:437–448. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Guo S, Chen W, Luo Y, Ren F, Zhong T, Rong
M, Dang Y, Feng Z and Chen G: Clinical implication of long
non-coding RNA NEAT1 expression in hepatocellular carcinoma
patients. Int J Clin Exp Pathol. 8:5395–5402. 2015.PubMed/NCBI
|
|
3
|
Waghray A, Murali AR and Menon KN:
Hepatocellular carcinoma: From diagnosis to treatment. World J
Hepatol. 7:1020–1029. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen KW, Ou TM, Hsu CW, Horng CT, Lee CC,
Tsai YY, Tsai CC, Liou YS, Yang CC, Hsueh CW, et al: Current
systemic treatment of hepatocellular carcinoma: A review of the
literature. World J Hepatol. 7:1412–1420. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Xie H, Ma H and Zhou D: Plasma HULC as a
promising novel biomarker for the detection of hepatocellular
carcinoma. Biomed Res Int. 2013:1361062013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xu WH, Zhang JB, Dang Z, Li X, Zhou T, Liu
J, Wang DS, Song WJ and Dou KF: Long non-coding RNA URHC regulates
cell proliferation and apoptosis via ZAK through the ERK/MAPK
signaling pathway in hepatocellular carcinoma. Int J Biol Sci.
10:664–676. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ilikhan SU, Bilici M, Sahin H, Akca AS,
Can M, Oz II, Guven B, Buyukuysal MC and Ustundag Y: Assessment of
the correlation between serum prolidase and alpha-fetoprotein
levels in patients with hepatocellular carcinoma. World J
Gastroenterol. 21:6999–7007. 2015.PubMed/NCBI
|
|
8
|
Quagliata L, Matter MS, Piscuoglio S,
Arabi L, Ruiz C, Procino A, Kovac M, Moretti F, Makowska Z,
Boldanova T, et al: Long noncoding RNA HOTTIP/HOXA13 expression is
associated with disease progression and predicts outcome in
hepatocellular carcinoma patients. Hepatology. 59:911–923. 2014.
View Article : Google Scholar :
|
|
9
|
Zhang G, Ha SA, Kim HK, Yoo J, Kim S, Lee
YS, Hur SY, Kim YW, Kim TE, Park YG, et al: Combined analysis of
AFP and HCCR-1 as an useful serological marker for small
hepatocellular carcinoma: A prospective cohort study. Dis Markers.
32:265–271. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fang TT, Sun XJ, Chen J, Zhao Y, Sun RX,
Ren N and Liu BB: Long non-coding RNAs are differentially expressed
in hepatocellular carcinoma cell lines with differing metastatic
potential. Asian Pac J Cancer Prev. 15:10513–10524. 2014.
View Article : Google Scholar
|
|
11
|
Brockdorff N, Ashworth A, Kay GF, McCabe
VM, Norris DP, Cooper PJ, Swift S and Rastan S: The product of the
mouse Xist gene is a 15 kb inactive X-specific transcript
containing no conserved ORF and located in the nucleus. Cell.
71:515–526. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Khachane AN and Harrison PM: Mining
mammalian transcript data for functional long non-coding RNAs. PLoS
One. 5:e103162010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang TH, Lin YS, Chen Y, Yeh CT, Huang YL,
Hsieh TH, Shieh TM, Hsueh C and Chen TC: Long non-coding RNA AOC4P
suppresses hepatocellular carcinoma metastasis by enhancing
vimentin degradation and inhibiting epithelial-mesenchymal
transition. Oncotarget. 6:23342–23357. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Huang JL, Zheng L, Hu YW and Wang Q:
Characteristics of long non-coding RNA and its relation to
hepatocellular carcinoma. Carcinogenesis. 35:507–514. 2014.
View Article : Google Scholar
|
|
15
|
Takahashi K, Yan IK, Kogure T, Haga H and
Patel T: Extracellular vesicle-mediated transfer of long non-coding
RNA ROR modulates chemosensitivity in human hepatocellular cancer.
FEBS Open Bio. 4:458–467. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang F, Ying HQ, He BS, Pan YQ, Deng QW,
Sun HL, Chen J, Liu X and Wang SK: Upregulated lncRNA-UCA1
contributes to progression of hepatocellular carcinoma through
inhibition of miR-216b and activation of FGFR1/ERK signaling
pathway. Oncotarget. 6:7899–7917. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu H, Lv Z and Guo E: Knockdown of long
noncoding RNA SPRY4-IT1 suppresses glioma cell proliferation,
metastasis and epithelial-mesenchymal transition. Int J Clin Exp
Pathol. 8:9140–9146. 2015.PubMed/NCBI
|
|
18
|
Mouraviev V, Lee B, Patel V, Albala D,
Johansen TE, Partin A, Ross A and Perera RJ: Clinical prospects of
long noncoding RNAs as novel biomarkers and therapeutic targets in
prostate cancer. Prostate Cancer Prostatic Dis. 19:14–20. 2016.
View Article : Google Scholar
|
|
19
|
Shi Y, Li J, Liu Y, Ding J, Fan Y, Tian Y,
Wang L, Lian Y, Wang K and Shu Y: The long noncoding RNA SPRY4-IT1
increases the proliferation of human breast cancer cells by
upregulating ZNF703 expression. Mol Cancer. 14:512015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sun M, Liu XH, Lu KH, Nie FQ, Xia R, Kong
R, Yang JS, Xu TP, Liu YW, Zou YF, et al: EZH2-mediated epigenetic
suppression of long noncoding RNA SPRY4-IT1 promotes NSCLC cell
proliferation and metastasis by affecting the
epithelial-mesenchymal transition. Cell Death Dis. 5:e12982014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xie HW, Wu QQ, Zhu B, Chen FJ, Ji L, Li
SQ, Wang CM, Tong YS, Tuo L, Wu M, et al: Long noncoding RNA
SPRY4-IT1 is upregulated in esophageal squamous cell carcinoma and
associated with poor prognosis. Tumour Biol. 35:7743–7754. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mazar J, Zhao W, Khalil AM, Lee B, Shelley
J, Govindarajan SS, Yamamoto F, Ratnam M, Aftab MN, Collins S, et
al: The functional characterization of long noncoding RNA SPRY4-IT1
in human melanoma cells. Oncotarget. 5:8959–8969. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Peng W, Wu G, Fan H, Wu J and Feng J: Long
noncoding RNA SPRY4-IT1 predicts poor patient prognosis and
promotes tumorigenesis in gastric cancer. Tumour Biol.
36:6751–6758. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang HM, Yang FQ, Yan Y, Che JP and Zheng
JH: High expression of long non-coding RNA SPRY4-IT1 predicts poor
prognosis of clear cell renal cell carcinoma. Int J Clin Exp
Pathol. 7:5801–5809. 2014.PubMed/NCBI
|
|
25
|
Tang J, Jiang R, Deng L, Zhang X, Wang K
and Sun B: Circulation long non-coding RNAs act as biomarkers for
predicting tumorigenesis and metastasis in hepatocellular
carcinoma. Oncotarget. 6:4505–4515. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tu ZQ, Li RJ, Mei JZ and Li XH:
Down-regulation of long non-coding RNA GAS5 is associated with the
prognosis of hepatocellular carcinoma. Int J Clin Exp Pathol.
7:4303–4309. 2014.PubMed/NCBI
|
|
27
|
Yamashita T, Kitao A, Matsui O, Hayashi T,
Nio K, Kondo M, Ohno N, Miyati T, Okada H, Yamashita T, et al:
Gd-EOB-DTPA-enhanced magnetic resonance imaging and
alpha-fetoprotein predict prognosis of early-stage hepatocellular
carcinoma. Hepatology. 60:1674–1685. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jain D: Tissue diagnosis of hepatocellular
carcinoma. J Clin Exp Hepatol. 4(Suppl 3): S67–S73. 2014.
View Article : Google Scholar
|
|
29
|
Huang M, Chen WM, Qi FZ, Xia R, Sun M, Xu
TP, Yin L, Zhang EB, De W and Shu YQ: Long non-coding RNA ANRIL is
up-regulated in hepatocellular carcinoma and promotes cell
apoptosis by epigenetically silencing of KLF2. J Hematol Oncol.
8:572015. View Article : Google Scholar
|
|
30
|
Khalil AM and Rinn JL: RNA-protein
interactions in human health and disease. Semin Cell Dev Biol.
22:359–365. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Khalil AM, Guttman M, Huarte M, Garber M,
Raj A, Rivea Morales D, Thomas K, Presser A, Bernstein BE, van
Oudenaarden A, et al: Many human large intergenic noncoding RNAs
associate with chromatin-modifying complexes and affect gene
expression. Proc Natl Acad Sci USA. 106:11667–11672. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Huarte M, Guttman M, Feldser D, Garber M,
Koziol MJ, Kenzelmann-Broz D, Khalil AM, Zuk O, Amit I, Rabani M,
et al: A large intergenic noncoding RNA induced by p53 mediates
global gene repression in the p53 response. Cell. 142:409–419.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cesana M, Cacchiarelli D, Legnini I,
Santini T, Sthandier O, Chinappi M, Tramontano A and Bozzoni I: A
long noncoding RNA controls muscle differentiation by functioning
as a competing endogenous RNA. Cell. 147:358–369. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhao Q, Li T, Qi J, Liu J and Qin C: The
miR-545/374a cluster encoded in the Ftx lncRNA is overexpressed in
HBV-related hepatocellular carcinoma and promotes tumorigenesis and
tumor progression. PLoS One. 9:e1097822014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Nagano T and Fraser P: No-nonsense
functions for long noncoding RNAs. Cell. 145:178–181. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chen LL and Carmichael GG: Decoding the
function of nuclear long non-coding RNAs. Curr Opin Cell Biol.
22:357–364. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Bussemakers MJ, van Bokhoven A, Verhaegh
GW, Smit FP, Karthaus HF, Schalken JA, Debruyne FM, Ru N and Isaacs
WB: DD3: A new prostate-specific gene, highly overexpressed in
prostate cancer. Cancer Res. 59:5975–5979. 1999.PubMed/NCBI
|
|
38
|
Kumarswamy R, Bauters C, Volkmann I, Maury
F, Fetisch J, Holzmann A, Lemesle G, de Groote P, Pinet F and Thum
T: Circulating long noncoding RNA, LIPCAR, predicts survival in
patients with heart failure. Circ Res. 114:1569–1575. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Liu Z, Shao Y, Tan L, Shi H, Chen S and
Guo J: Clinical significance of the low expression of FER1L4 in
gastric cancer patients. Tumour Biol. 35:9613–9617. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Tsui NB, Ng EK and Lo YM: Stability of
endogenous and added RNA in blood specimens, serum, and plasma.
Clin Chem. 48:1647–1653. 2002.PubMed/NCBI
|
|
41
|
Hu X, Bao J, Wang Z, Zhang Z, Gu P, Tao F,
Cui D and Jiang W: The plasma lncRNA acting as fingerprint in
non-small-cell lung cancer. Tumour Biol. Oct 9–2015.Epub ahead of
print.
|
|
42
|
Xie M, Nie FQ, Sun M, Xia R, Liu YW, Zhou
P, De W and Liu XH: Decreased long noncoding RNA SPRY4-IT1
contributing to gastric cancer cell metastasis partly via affecting
epithelial-mesenchymal transition. J Transl Med. 13:2502015.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Khaitan D, Dinger ME, Mazar J, Crawford J,
Smith MA, Mattick JS and Perera RJ: The melanoma-upregulated long
noncoding RNA SPRY4-IT1 modulates apoptosis and invasion. Cancer
Res. 71:3852–3862. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhang L, Yang F, Yuan JH, Yuan SX, Zhou
WP, Huo XS, Xu D, Bi HS, Wang F and Sun SH: Epigenetic activation
of the MiR-200 family contributes to H19-mediated metastasis
suppression in hepatocellular carcinoma. Carcinogenesis.
34:577–586. 2013. View Article : Google Scholar
|
|
45
|
Ma L, Ji L, Yu Y and Wang J: Novel
molecular targets for diagnosis and treatment of hepatocellular
carcinoma. Discov Med. 19:7–14. 2015.PubMed/NCBI
|
|
46
|
Lee B, Mazar J, Aftab MN, Qi F, Shelley J,
Li JL, Govindarajan S, Valerio F, Rivera I, Thurn T, et al: Long
noncoding RNAs as putative biomarkers for prostate cancer
detection. J Mol Diagn. 16:615–626. 2014. View Article : Google Scholar : PubMed/NCBI
|
